Status:
UNKNOWN
Microbiota and Symptom Distress in Head and Neck Cancer Patients Receiving Radiotherapy
Lead Sponsor:
Taipei Medical University
Conditions:
Oral Mucositis
Microbiota
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
The investigators plan to conduct a 3-year pioneering care research project for mucositis in cancer patients. These include: (1) an analysis of the incidence and severity of mucositis, severity, treat...
Detailed Description
Mucositis is common among cancer patients receiving radiotherapy and chemotherapy. A total of 80-100% of the patients are suffering from the mucositis pain; their regular dieting is disturbed, nutriti...
Eligibility Criteria
Inclusion
- \- age≧20 years old diagnosed as head and neck cancer patients Plan to Receive radiation therapy Consciousness, ability to complete research assessment and willing to participate in research Patients can be communicated in Mandarin and Taiwanese, and complete the questionnaire on their own or with the help of researchers.
Exclusion
- \- History of allergic to honey, propolis, various pollen, alcohol People with mental disorders or cognitive dysfunction Diabetes mellitus Critical of end of life patient
Key Trial Info
Start Date :
April 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04843644
Start Date
April 10 2021
End Date
July 31 2025
Last Update
April 13 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.